insights_auto
Why is INO down 10,49%?
Dive Deeperchevron_right
INO:NASDAQ
Inovio Pharmaceuticals Inc
1,45 USD
arrow_downward
-10,49%(-0,17) 1D
1,23 USD
arrow_downward
-15,21% (-0,22)bedtimeAfter hours
Closed: 5-ноя., 16:00:02 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Open
1,57 USD
High
1,59 USD
Low
1,40 USD
Mkt. cap
149,93 млн
Avg. vol.
15,72 млн
Volume
16,58 млн
52-wk high
2,72 USD
52-wk low
0,57 USD
EPS
-1,17 USD
Beta
1,71
Shares outstanding
103,40 млн
No. of employees
112
Open
1,57 USD
High
1,59 USD
Low
1,40 USD
Mkt. cap
149,93 млн
Avg. vol.
15,72 млн
Volume
16,58 млн
52-wk high
2,72 USD
52-wk low
0,57 USD
EPS
-1,17 USD
Beta
1,71
Shares outstanding
103,40 млн
No. of employees
112
News stories
From web sources and news partners
News Corp
·
3 саат мурун
Inovio Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors
Investing.com
·
3 саат мурун
Inovio announces proposed public offering of common stock
Benzinga
·
4 саат мурун
12 Health Care Stocks Moving In Thursday's After-Market Session
TradingView
·
4 саат мурун
INOVIO Announces Proposed Public Offering of its Common Stock
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc